In Brief: Adac Labs
This article was originally published in The Gray Sheet
Executive Summary
Adac Labs: Firm's MCD/ACTM (Molecular Coincidence Detection with Attenuation Correction) technology receives 510(k) clearance, permitting the firm to add the distortion-reducing feature to its nuclear medicine imaging systems. By correcting for "image distortions created by non-uniform attenuation of soft tissue in the human body," MCD/ACTM permits Adac's systems to perform both single photon emission computed tomography and coincidence imaging, the company explains...